Sivik Global Healthcare LLC Sells 5,000 Shares of Cardinal Health, Inc. $CAH

Sivik Global Healthcare LLC decreased its holdings in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) by 10.0% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 45,000 shares of the company’s stock after selling 5,000 shares during the quarter. Cardinal Health comprises about 2.1% of Sivik Global Healthcare LLC’s investment portfolio, making the stock its 9th biggest position. Sivik Global Healthcare LLC’s holdings in Cardinal Health were worth $7,560,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the business. MassMutual Private Wealth & Trust FSB boosted its holdings in shares of Cardinal Health by 3.6% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company’s stock worth $297,000 after purchasing an additional 62 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its holdings in shares of Cardinal Health by 0.4% during the second quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 17,805 shares of the company’s stock worth $2,991,000 after purchasing an additional 69 shares during the last quarter. Perigon Wealth Management LLC boosted its holdings in shares of Cardinal Health by 3.2% during the second quarter. Perigon Wealth Management LLC now owns 2,314 shares of the company’s stock worth $389,000 after purchasing an additional 72 shares during the last quarter. Community Bank & Trust Waco Texas boosted its holdings in shares of Cardinal Health by 1.3% during the second quarter. Community Bank & Trust Waco Texas now owns 5,598 shares of the company’s stock worth $940,000 after purchasing an additional 74 shares during the last quarter. Finally, Pinnacle Bancorp Inc. boosted its holdings in shares of Cardinal Health by 11.2% during the first quarter. Pinnacle Bancorp Inc. now owns 767 shares of the company’s stock worth $106,000 after purchasing an additional 77 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Price Performance

NYSE:CAH opened at $156.86 on Friday. The business’s 50-day moving average is $152.09 and its two-hundred day moving average is $151.21. Cardinal Health, Inc. has a 12 month low of $106.98 and a 12 month high of $168.44. The firm has a market capitalization of $37.27 billion, a PE ratio of 24.32, a price-to-earnings-growth ratio of 1.33 and a beta of 0.71.

Cardinal Health (NYSE:CAHGet Free Report) last released its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. During the same period last year, the company posted $1.84 earnings per share. The firm’s revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a dividend of $0.5107 per share. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. Cardinal Health’s dividend payout ratio (DPR) is currently 31.63%.

Analyst Ratings Changes

Several research analysts recently weighed in on the company. Leerink Partners increased their target price on Cardinal Health from $186.00 to $187.00 and gave the stock an “outperform” rating in a research report on Monday, October 6th. UBS Group reaffirmed a “buy” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Robert W. Baird increased their target price on Cardinal Health from $197.00 to $203.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 13th. Argus set a $189.00 target price on Cardinal Health in a research report on Friday, August 22nd. Finally, Jefferies Financial Group set a $150.00 target price on Cardinal Health in a research report on Tuesday, August 12th. Twelve analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $166.00.

Get Our Latest Stock Analysis on Cardinal Health

Insider Activity at Cardinal Health

In other news, CEO Stephen M. Mason sold 41,575 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the sale, the chief executive officer directly owned 26,085 shares in the company, valued at $3,881,969.70. This trade represents a 61.45% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jessica L. Mayer sold 38,078 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the sale, the insider owned 48,457 shares of the company’s stock, valued at $7,211,370.74. This represents a 44.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 271,676 shares of company stock valued at $40,489,525. 0.12% of the stock is currently owned by insiders.

Cardinal Health Company Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Featured Articles

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.